Germany At its core, we need a reform of the welfare state. It’s indispensable, but it needs to be brought back to its core purpose: help for those who need it – not excessive transfer payments Klaus Holetschek served as Bavarian Health Minister during the pandemic and now chairs the CSU…
Germany My long-term hope is that dialysis will become much less common because we are able to diagnose and treat kidney disease earlier and more effectively Prof. Dr. Jörg Latus is passionate about the future of kidney care and the growing potential to prevent or slow disease progression. As Medical Director…
Germany We believe that flexibility, analytical drive, initiative, and a detailed, hands-on mindset are more important than industry experience Peter Gerckens, CEO at PharmaSGP combines a strong background in consulting, branding, and consumer healthcare with an entrepreneurial approach to pharmaceutical growth. He emphasizes data-driven decision-making, small, agile teams, and in-house capabilities…
Germany Tomas Mihal, General Manager for Germany at STADA, discusses the company’s diversified three-pillar model across consumer healthcare, generics and specialty medicines, highlighting its strong German market position, agile culture and five-year growth strategy. He outlines his priorities around acquisitions, digital and e-commerce expansion, selective biosimilar and innovation opportunities, supply resilience,…
Germany Collaboration across institutions is not optional – it is necessary. The pace and complexity of the challenges demand it. As CEO of TUM University Hospital Munich, Dr med Martin Siess is trying to close a gap that has long dogged German medicine: strong basic research that rarely makes it to…
Korea I believe we can position Korea as a true global leader in biohealth innovation Lee Hyung Hoon, Vice Minister at Korea’s Ministry of Health and Welfare, outlines his vision for strengthening universal healthcare while positioning Korea as a global biohealth leader. He discusses AI-driven healthcare, regulatory reform, regional access, supply…
Germany We want to provide all patients – privately or publicly insured – with rapid access to innovative therapies Germany’s statutory health insurers are under growing pressure to control pharmaceutical spending without compromising patient access to innovative therapies. As one of the country’s largest purchasing associations, GWQ ServicePlus AG pools the…
Germany Dr Gertrud Demmler of SBK, one of Germany’s largest statutory health insurance funds, describe the EUR 18 billion funding gap facing the country’s health system, what the July 2026 GKV Contribution Rate Stabilisation Act does and doesn’t fix, why consolidation among health insurance funds is set to continue, and the…
Germany Stephan Pilsinger, Member of the German Bundestag (CSU) and Deputy Chair of the Health Committee, has publicly criticised the government’s savings package over cuts to organ-donation counselling — even as he defends the broader austerity drive as necessary. In this conversation, the practicing GP and CDU/CSU lead rapporteur on pharmaceutical…
Germany Serdar Yüksel spent two decades as a nurse before 15 years in North Rhine-Westphalia’s state parliament, and now represents the SPD on the Bundestag’s Health Committee. He discusses the jump from state to federal politics, the SPD’s push to stabilise health insurance contributions fairly across government, insurers, providers, industry and…
Global Five conferences, anxiety spreading across five continents, one unmistakable pattern: the global pharmaceutical industry is transforming at a dizzying pace. From Philadelphia to Geneva, from Istanbul to Chicago and London, the Shawview Consulting team picked up the same recurring threads in every panel and hallway conversation: AI and real-world data…
Europe The goal is not only to generate scientific breakthroughs, but to ensure that these breakthroughs reach patients faster and more reliably Professor Gerd Geisslinger serves as Chair of Clinical Pharmacology at Goethe University Hospital and as Executive Director of the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), which is…
See our Cookie Privacy Policy Here